Best Bio is a developer of cell therapy products and gene therapy products, focusing on the development of new gene-edited NK cell therapy products and gene therapy products. A complete NK cell genetic engineering platform has been established and the proof of concept has been completed. Recently, Best Biotech completed tens of millions of US dollars in Series A financing, led by Great Eagle VC in Hong Kong, followed by BV Baidu Ventures, Xinxi Capital, Guangda Huitong, and SPARK VC in the UK. Existing shareholder Honghui Fund continued to invest , Huaxing Capital acted as the exclusive financial advisor.
This article is transferred from: https://www.itjuzi.com/investevent/13776811
This site is only for collection, and the copyright belongs to the original author.